2022/07/04
Novation and UofMontreal present at Target ALS annual meeting in Boston, MA2022/01/19
Dr. Roland Bürli joins Novation's Scientific Advisory Board2021/04/30
Novation and UofMontreal/CRCHUM consortia present at Target ALS annual meeting2020/07/13
Target ALS award for Novation and UofMontreal/CRCHUM collaboration2018/12/04
Novation presents at first RNA-targeted drug discovery summit2016/01/19
Dr. Andrew MacKenzie joins Novation's Scientific Advisory Board2016/01/01
Novation files US patent on oral cytokine inhibitor2013/05/07
Novation establishes research collaboration with Boehringer Ingelheiim2013/04/22
Novation receives Notice of Issuance by Canadian Patent office for QUEST Technology2012/10/22
Novation receives Notice of Allowance by Canadian Patent office for QUEST Technology2010/07/20
Novation receives contribution from NRC IRAP2009/06/11
Novation and Cancer Therapeutics begin collaboration on discovery and development of new cancer therapies2009/06/02
Notice of Allowance from US Patent Office for Quest Drug Discovery Technology2009/01/07
Quest drug discovery assay available for identifying inhibitors of IL-62008/11/17
Quest oncology drug discovery assays for intractable cancer targets2008/10/30
Drug discovery assay for identifying new therapeutics for neurological diseases2008/09/11
Dr. Inder Verma joins Novation Scientific Advisory Board2007/09/04
Novation receives Notice of Intent to Grant from European Patent Office2006/02/05
Novation appoints two new members to Board of Directors2005/11/23
Novation Pharmaceuticals Commences mRNA Small Molecule Drug Discovery Project with Novartis
A NEW PARADIGM IN SMALL-MOLECULE DRUG DISCOVERY
Novation Pharmaceuticals is using a new approach, modulation
of intracellular messenger RNA (mRNA), to identify new small-molecule therapies to treat serious
diseases. Novation's technology, called QUEST, is a breakthrough in identifying new,
orally active small molecule drugs for significant therapeutic targets.
Novation is seeking to build a product focused business based on modulation of mRNA. Priority is to discover its
own products using QUEST, whilst generating early revenues through strategic partnerships with pharmaceutical companies.
Novation's QUEST technology -- taking drug discovery to a new level
Copyright © 2003 - 2024 Novation Pharmaceuticals, Inc. All rights reserved.